In animal models, PXR ablation suppresses HFD-induced obesity, steatosis, and insulin resistance,488 whereas PXR activation recapitulates key features of MASLD and MASH, including steatosis, inflammation, and lipotoxicity.452. Here, NR1I2 is linked to steatosis.